Heart disease is one of the leading causes of deaths reported worldwide. People with high levels of cholesterol are more prone to heart attack than others. Thus, leaders in the healthcare industry are emphasizing on the availability of real-time data and monitoring for better care delivery. In this context, it has been found by Market Research Future (MRFR)’s report that the Global Cholesterol Management Devices Market is forecasted to mark a robust CAGR of 8.5% during the assessment period 2017 to 2023.
According to World Health Organization (WHO)’s data published in 2014, over 600 million people were obese. Obesity is one of the consequences of increasing levels of bad cholesterol and is highly prevalent across the world. The drastic changes in lifestyle, as well as food habits, are expected to propel the incidences of obesity over the next couple of years. This, in turn, is anticipated to motivate the players of the cholesterol management devices market to make testing accessible at home and point of care centers. The introduction of at-home testing kits is likely to revolutionize the future trajectory of the market in the forthcoming years.
Get Free Sample @ https://www.marketresearchfuture.com/sample_request/1045
The increasing awareness about the ill-effects of high cholesterol levels in conjunction with a shift towards a healthy lifestyle is poised to fuel demand for these devices. Also, the support extended by the governments for the acceleration of research & development activities is presumed to influence the proliferation of the cholesterol management devices market across the review period. On the contrary, the lack of awareness among the patient population remains an impediment to market growth.
Cholesterol Management Devices Market – Competitive Dashboard
The major players expected to contribute significantly towards the development of the Cholesterol Management Devices Market are profiled in this MRFR report which includes
- Boston Scientific Corporation (US)
- Jude Medical, LLC. (Canada)
- Medtronic (US)
- Koninklijke Philips N.V. (US)
- Abbott (US)
- Roche Diagnostics (US)
- Alere (US)
- BIOTRONIK SE & Co. KG (Germany)
- Sorin Group (Italy)
- Bio-AMD (UK)
Industry News:
In May 2019
The at-home health testing platform, LetsGetChecked, has announced the closing of USD 30 Mn in its Series B round. At present, the portfolio of the company includes wellness testing (cholesterol, thyroid, etc.), sexual health testing, cancer screening, fertility testing, pharmacogenomic testing, etc.
In January 2019
Kroger, an American retailing company, has deployed point-of-care blood testing devices, CardioChek Plus, at all of its health care locations for the prevention of heart diseases. The handheld device measures total cholesterol, triglycerides, HDL cholesterol, and glucose for providing real-time readings.
Cholesterol Management Devices Market – Segmentation
By type, the Global Cholesterol Management Devices Market has been segmented into monitors, wrist monitors, small portable instruments, meters, wireless systems, and others.
Based on applications, the cholesterol management devices market has been segmented into hypercholesterolemia, hypocholesterolemia, cholesterol testing, and others.
By end-users, the global cholesterol management devices market has been segmented into home-based healthcare, hospitals, clinics, and others.
Cholesterol Management Devices Market – Regional Analysis
The geographical study of the Global Cholesterol Management Devices Market encompasses four major regions, viz. Americas, Europe, Asia Pacific and the Middle East & Africa (MEA). Americas is projected to continue its dominance over the next few years. Millions of people are diagnosed with high cholesterol level in the U.S. alone. In addition, the developed healthcare infrastructure coupled with the consolidation of major market participants in the region is poised to work in favor of the growth of the cholesterol management devices market in the upcoming years. Europe has been forecasted to thrive continuously at its second spot over the assessment period. Meanwhile, Asia Pacific signifies the grandest opportunities for growth. It is poised to attract massive investments and strike the steepest rise in the growth curve across the forecast period.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com